Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Kcnmb1 genotype influences response to verapamil sir and adverse outcomes in the international verapamil sr/trandolapril study (invest)

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Beitelshees, A. L.
  • Gong, Y.
  • Wang, D.
  • Schork, Nicholas
  • Cooper-DeHoff, R. M.
  • Langaee, T. Y.
  • Shriver, M. D.
  • Sadee, W.
  • Knot, H. J.
  • Pepine, C. J.
  • Johnson, J. A.
  • Invest Investigators

publication date

  • September 2007

journal

  • Pharmacogenetics and Genomics  Journal

subject areas

  • Aged
  • Antihypertensive Agents
  • Base Sequence
  • Calcium Channel Blockers
  • DNA Primers
  • Female
  • Genotype
  • Humans
  • Hypertension
  • Indoles
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits
  • Male
  • Middle Aged
  • Pharmacogenetics
  • Polymorphism, Single Nucleotide
  • Verapamil
scroll to property group menus

Research

keywords

  • KCNMB1
  • polymorphism
  • verapamil SIR
scroll to property group menus

Identity

PubMed Central ID

  • PMC2713584

International Standard Serial Number (ISSN)

  • 1744-6872

Digital Object Identifier (DOI)

  • 10.1097/FPC.0b013e32810f2e3c

PubMed ID

  • 17700361
scroll to property group menus

Additional Document Info

start page

  • 719

end page

  • 729

volume

  • 17

issue

  • 9

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support